Drugs that contain Naloxone Hydrochloride

1. Drug name - EVZIO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9056170 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery Nov, 2024

(2 years from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US10314977 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery Jan, 2025

(2 years from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery Apr, 2025

(2 years from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery Feb, 2026

(3 years from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery Mar, 2026

(3 years from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery Jun, 2026

(3 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery Jun, 2026

(3 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system Feb, 2027

(4 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery Feb, 2027

(4 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery May, 2027

(4 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery Mar, 2028

(5 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery Oct, 2028

(6 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system Nov, 2028

(6 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring Apr, 2029

(6 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output Nov, 2029

(7 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US10143972 KALEO INC Ultrafiltration membrane and a preparation method thereof May, 2031

(8 years from now)

US8627816 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2032

(9 years from now)

US9517307 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone Jul, 2034

(11 years from now)

US10220158 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone Mar, 2035

(12 years from now)

Treatment: Method for confirming dose delivery; Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone; Use of an auto injector to administer naloxone hcl; Use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
0.4MG/0.4ML (0.4MG/0.4ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Discontinued

2. Drug name - EVZIO (AUTOINJECTOR)

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10314977 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US7918823 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US9737669 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8361029 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8425462 KALEO INC Devices, systems, and methods for medicament delivery Nov, 2024

(2 years from now)

US10737028 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US9056170 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8608698 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US8313466 KALEO INC Devices, systems and methods for medicament delivery Nov, 2024

(2 years from now)

US7731690 KALEO INC Devices, systems and methods for medicament delivery Jan, 2025

(2 years from now)

US8016788 KALEO INC Devices, systems and methods for medicament delivery Mar, 2025

(2 years from now)

US10335549 KALEO INC Devices, systems and methods for medicament delivery Apr, 2025

(2 years from now)

US9278182 KALEO INC Devices, systems and methods for medicament delivery Feb, 2026

(3 years from now)

US8926594 KALEO INC Devices, systems and methods for medicament delivery Mar, 2026

(3 years from now)

US7731686 KALEO INC Devices, systems and methods for medicament delivery Jun, 2026

(3 years from now)

US10960155 KALEO INC Devices, systems and methods for medicament delivery Jun, 2026

(3 years from now)

US9238108 KALEO INC Medicament delivery device having an electronic circuit system Feb, 2027

(4 years from now)

US8206360 KALEO INC Devices, systems and methods for medicament delivery Feb, 2027

(4 years from now)

US9724471 KALEO INC Devices, systems, and methods for medicament delivery May, 2027

(4 years from now)

US7947017 KALEO INC Devices, systems and methods for medicament delivery Mar, 2028

(5 years from now)

US7749194 KALEO INC Devices, systems, and methods for medicament delivery Oct, 2028

(6 years from now)

US8231573 KALEO INC Medicament delivery device having an electronic circuit system Nov, 2028

(6 years from now)

US8226610 KALEO INC Medical injector with compliance tracking and monitoring Apr, 2029

(6 years from now)

US8021344 KALEO INC Medicament delivery device configured to produce an audible output Nov, 2029

(7 years from now)

US8939943 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US9474869 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US10322239 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US9022022 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2031

(8 years from now)

US10143792 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone May, 2031

(8 years from now)

US8627816 KALEO INC Medicament delivery device for administration of opioid antagonists including formulations for naloxone Feb, 2032

(9 years from now)

US9517307 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone Jul, 2034

(11 years from now)

US10220158 KALEO INC Devices and methods for delivering opioid antagonists including formulations for naloxone Mar, 2035

(12 years from now)

Treatment: Method for confirming dose delivery; Use of a delivery device to administer a dose of naloxone; Use of a delivery device to deliver a dose of naloxone; Use of an auto injector to administer naloxone hcl; Use of a delivery device to deliver a bioequivalent dose of a naloxone composition via a needle

Dosage: SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage
Strength Dosage Availability
2MG/0.4ML (2MG/0.4ML) SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS Discontinued

3. Drug name - KLOXXADO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10722510 HIKMA Liquid naloxone spray Aug, 2034

(11 years from now)

US10973814 HIKMA Liquid naloxone spray Aug, 2034

(11 years from now)

Treatment: Use of naloxone for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and pediatric patients

Dosage: SPRAY;NASAL

More Information on Dosage
Strength Dosage Availability
8MG/SPRAY SPRAY;NASAL Prescription

4. Drug name - NARCAN

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9629965 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US10085937 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US9480644 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US9775838 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US9561177 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US9707226 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US9468747 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

US9211253 EMERGENT Nasal drug products and methods of their use Mar, 2035

(12 years from now)

Treatment: Use of naloxone hydrochloride for emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
2MG/SPRAY SPRAY, METERED;NASAL Discontinued
4MG/SPRAY SPRAY, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.